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Novelty Statements  
 
 Teenagers and young adults with DKA are treated largely according to national 
guidelines 
 Monitoring during treatment is not always done according to guidelines, especially in 
young adults 
 The incidence of hypoglycaemia is high in teenagers and young adults 
 The incidence of hypokalaemia in young adults is high 
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Abstract 
Objectives 
Management of diabetic ketoacidosis (DKA) in young people differs in the UK 
between adult and paediatric services, but outcomes and extent of use of national 
guidelines are unknown.  
Methods 
A standardised questionnaire was sent to all paediatric[KD1] and adult diabetes 
services in England, requesting details of all DKA admissions in young people over 
the age of 14 years in Paediatric services (‘paediatrics’), and in young adults up to 
the age of 22 years in Adult services (‘adults’).  
Results 
64 ‘adult’ patients aged 22 or under were reported (mean 19.2yr); 7 were aged 
between 10 and 16yr. 71 ‘paediatric’ patients were reported (mean 14.9yr; range 
11-18). 85% paediatric and 69% adult patients [KD2]were treated according to 
national guidelines.  89% adult and 99% paediatric patients [KD3]were treated with 
0.9% saline and fixed-rate insulin infusions; 16% adults had an insulin bolus.  
Insulin treatment was delayed in paediatric compared with adult patients (100min 
vs 39min, p<0.001).   
23% of potassium levels in adult and 8.8% in paediatric patients were below 
3.5mmol/l (p< 0.005).  Lowest mean potassium levels were 3.8mmol/l in paediatric 
and 3.5mmol/l in adult patients (p<0.005).  Hypoglycaemia occurred in 42.3% 
paediatric and 36% adult patients.  
Time to resolution was similar in adult (18.2hr) and paediatric patients (16.0hr), as 
was duration of hospital stay (2.53 vs 2.35 days).    
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Conclusions 
Young people are treated according to national guidelines, but the quality of 
monitoring was variable in both paediatric and adult settings.  The incidence of 
hypoglycaemia and hypokalaemia was unacceptably high. 
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Diabetic ketoacidosis (DKA) is a common cause of hospital admission and a 
significant contributor to mortality and morbidity in people with type 1 diabetes 
[1,2].  Guidelines for the management of DKA in children have been available in 
the UK through the British Society of Paediatric Endocrinology and Diabetes 
(BSPED) since 1994 and are now widely used in paediatric departments [3].  
Management guidelines have developed over the last 20 years to take into account 
emerging evidence for the prevention of cerebral oedema, which is the most 
serious complication of DKA in children and young people [4].  This includes 
reduced fluid volumes, delay in starting insulin infusion and emphasis on close 
monitoring [5,6,7]. 
 
The management of DKA in adults has historically involved giving significantly 
larger amounts of fluid in rehydration, and the use of variable insulin doses.  In 
2010 the UK Joint British Diabetes Societies (JBDS) published national guidance 
on the management of DKA [8,9], and revised this in 2013 [10].  These guidelines 
have become more similar to paediatric guidelines in that recommended fluid 
volumes have been reduced, and a weight based, fixed rate intravenous insulin 
infusion is advised.  Guidance on fluid type and potassium replacement is also 
given [11]. 
 
Alongside a national survey of the management of DKA in adults against the 
standards in the JBDS guidelines, whose results have been reported elsewhere 
[12], we also conducted a survey of the management and outcomes of DKA in 
teenagers in paediatric services. 
 
 5 
The aim of this joint survey was to examine the quality of management of young 
people (under the age of 22 years) against the JBDS guidelines [9[KD4]] in adult 
services, and the BSPED guidelines [3] for paediatric services, and study the 
differences in management and outcomes. 
 
 
Research Design and Methods 
A data collection questionnaire was developed using the 2013 JBDS guideline as a 
template [9][KD5].  The questionnaire was adapted slightly for paediatric services as 
some questions were not appropriate, although the majority remained the same 
[See online materials - Appendices 1 and 2].     
 
Adult services were identified through the databases of Diabetes UK, the 
Association of British Diabetologists and the Diabetes Inpatient Specialist Nurse 
UK Group.  Paediatric diabetes services were identified through the Regional 
Paediatric Diabetes Networks and the Association of Children’s Diabetes 
Clinicians.  The questionnaires were sent out by email to all 220 UK specialist adult 
diabetes teams and 185 paediatric diabetes services in England and Wales.  One 
clinician from each service was asked to fill in a single form for each of the 
subsequent 5 patients at their institution (for paediatrics, those over the age of 14) 
with a diagnosis of DKA and return them between May and December 2014.  
 
For this comparison of teenage and young adult DKA, all the paediatric responses 
were included as well as the adult responses relating to young people aged 22 and 
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under. These are termed ‘paediatric’ and ‘adult’ regardless of the age of the 
patient.   
 
T-tests and analysis of variance (ANOVA) were used to compare groups.   
 
The Clinical Audit and Improvement Department of the Norfolk and Norwich 
University Hospitals NHS Foundation Trust deemed this survey a service 
improvement exercise and confirmed that the project did not require multi-site 
ethical, research governance or audit approval.   
 
Results: 
Clinical details  
Paediatric - 71 forms were received from 56 hospitals. Each form represented an 
individual admission for a unique patient. The mean age was 14.9 years (SD 1.4).  
Adult – of the 283 forms received in the full adult survey, 64 patients were aged 22 
or under.  The mean age of this group was 19.2 years (SD 2.3).  Adult physicians 
reported 7 younger teenagers aged 10 to 16 receiving DKA management from 
adult teams. These children and young people were cared for in adult 
environments using the adult guidelines.   
 
The participating hospitals reporting these patients are listed in Appendix 3.  The 
forms were completed by a mix of consultants, trainees and diabetes specialist 
nurses.  
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The median length of stay in the paediatric patients was 1.85 days (IQR 1.00, 2.74) 
with a mean of 2.35 days (SD 2.3), and in the adult patients was 2.0 days (IQR 
1.12, 2.67) with a mean of 2.53 days (SD 2.4), p=0.3.  One paediatric patient and 6 
adult patients developed DKA as an existing in-patient.  Table 1 shows the clinical 
site of care of the patients.   
 
37.2% of paediatric patients and 42.2% of adult patients had had at least 1 
previous admission for DKA in the preceding 12 months (median 2, range 1 - 7).  
Reasons for admission in DKA are given in Table 2.  Only 1 paediatric patient 
(1.6%) and 3 adult patients (4.7%) in these cohorts had DKA as the new 
presentation of Type 1 diabetes.   
 
Diagnosis criteria and adherence to guidelines 
Admission mean pH (±SD) was 7.17 (±0.19) in paediatric and 7.15 (±0.20) in adult 
patients.  Mean plasma glucose was 25.0mmol/l (±6.9) in paediatric and 
26.8mmol/l (±8.5) in adult patients, and mean bicarbonate was 11.3mmol/l (±4.3) in 
paediatric and 11.0mmol/l (±4.7) in adult patients.  Mean blood ketone level was 
5.65 mmol/l (±1.15) in paediatric and 5.45 mmol/l (±1.44) in adult patients.  There 
were no differences between the adult and paediatric patients in any of these 
criteria. 11 paediatric and 9 adult patients did not have blood ketone 
measurements.   
 
Four paediatric patients and 7 adult patients had a pH of 7.3 or greater but only 1 
adult patient did not have DKA on any criterion.  One paediatric patient had a pH 
>7.3, bicarbonate of >15 but no blood ketone measurement although urine ketones 
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of 4+.  These patients were still included in the analysis as their management was 
the same as the remainder.   
 
Details of treatment given and investigations carried out during the first 24 hours 
are shown in Table 3.   
 
87% adult units and 96% of paediatric units reported that they followed national 
guidelines.  However only 60 paediatric patients (84.5%) were treated according to 
BSPED guidelines (7 were not and 4 missing), and only 49 adult patients (76.6%) 
were treated according to JBDS guidelines (9 were not and 6 missing).  
 
Fluid 
Intravenous 0.9% sodium chloride solution was first started a median of 34 minutes 
after admission (IQR 18, 78) in paediatric patients and 36 minutes after admission 
(IQR 15, 80) in adult patients.  45 of the paediatric patients were given a 0.9% 
sodium chloride bolus dose (their mean pH was 7.14 ± 0.15) and 23 were not 
(mean pH 7.23 ± 0.05, p=0.005).  Table 3 shows issues surrounding the diagnosis 
and management of the patients during the first hour after admission. Senior 
review (i.e. registrar or consultant) occurred within the first 12 hours in 76% 
paediatric patients and 84% of adult patients.  
 
Insulin 
An insulin bolus was given to 11 (17%) adult patients; 2 of these had severe DKA 
with a pH of less than 7.1, and two were under the age of 18 years.  Bolus doses 
were not used in paediatric care.  Time from diagnosis to starting intravenous 
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insulin infusion was 39 minutes (IQR 19, 72) in adult patients and 100 minutes 
(IQR 84, 116) in paediatric patients (p<0.001).  Of the paediatric patients, 61 
started on an infusion rate of 0.1 Units/kg/hr, and 9 started at a rate of 0.05 
Units/kg/hr.  Although the mean pH of the two groups was no different (7.17 ± 0.02 
vs 7.14 ± 0.04; p=0.26), those treated with 0.05 Units/kg/hr took significantly longer 
to reach DKA resolution (median 21.4 hours compared with 15.3 hours; p=0.015).  
The small group given the lower insulin dose were younger (13.9 ± 2.4 yr) than the 
larger group receiving the higher dose (15.0 ± 1.8 yr; p<0.02).  As the majority of 
the adult patients were treated according to the JBDS guidelines, it was assumed 
that the insulin infusion was given at a rate of 0.1 Units/kg/hr. Their median time to 
resolution was 18.2 hours. 
 
In patients already using long-acting insulin, this was more likely to be continued in 
adult patients (88%) than in paediatric patients (45%).   
 
Biochemical changes during the first 24 hours 
Glucose  
44% of paediatric patients and 36% adult patients became hypoglycaemic (blood 
glucose (BG) levels less than 4.0mmol/l) during the first 24 hours of treatment. 18 
of 57 adult patients (32%) became hypoglycaemic if the glucose concentration in 
the intravenous fluid was changed to 10% when the BG fell to 14 mmol/l, but 5 of 7 
patients (71%) became hypoglycaemic if 10% glucose was not used.  In paediatric 
patients, the glucose concentration was changed to 10% in 37 (of whom 16 (43%) 
became hypoglycaemic), but not in 27 patients (of whom 14 (52%) became 
 10 
hypoglycaemic).  None of the paediatric patients (n=9) starting on the lower insulin 
infusion rate (0.05 Units/kg/hour) became hypoglycaemic during the first 24 hours.   
 
Potassium 
The mean potassium on admission was 4.8mmol/l (±1.0) in paediatric patients and 
4.8mmol/l (±0.8) in adult patients. Figures 1 and 2 show the changes in pH and 
potassium values during the course of the 24 hours following admission in both 
groups.  Mean potassium levels gradually fell over the first 24 hours in both groups.  
The mean lowest recorded potassium during the admission was 3.8mmol/l (± 0.5) 
in paediatric patients, but 3.5mmol/l (± 0.6) in adult patients, p<0.005.  23.6% of all 
potassium levels measured over the first 24 hours in adult patients, but only 8.8% 
in paediatric patients were below 3.5 mmol/l (p<0.005).   Those paediatric patients 
starting on the lower insulin rate (0.05 Units/kg/hour) had no less hypokalaemia 
than those starting at the higher rate (14.3% compared with 7.9% total potassium 
levels less than 3.5mmol/l).  In adult patients, lowest potassium levels were no 
lower in those given a bolus dose of insulin (3.8 ± 0.4 mmol/l) than in those who 
were not (3.5 ± 0.6 mmol/l, p=0.2). 
 
There was no difference in the risk of developing either hypokalaemia or 
hypoglycaemia between those respondents who followed the national guidelines 
and those who did not.  
 
Monitoring during hospital admission 
Table 4 shows the extent of monitoring in paediatric and adult patients; paediatric 
patients were more likely to receive appropriate monitoring during their DKA 
episode. 
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Resolution of DKA and discharge planning  
The median length of time to resolution of DKA in the paediatric patients was 16.03 
hours (IQR 10.0, 21.03) and in the adult patients was 18.18 hours (IQR 9.66, 
34.12).  Table 4 shows the steps involved at the resolution of DKA and transfer 
onto subcutaneous insulin.  The majority of paediatric and adult patients had some 
educational input, but very few of either group had any psychology input before 
discharge.  
 
Conclusions 
This large study is the first to compare the management of DKA in young adults 
and adolescents on a national basis.  The quality of care is generally good in both 
adult and paediatric services, and the majority of patients receive appropriate 
monitoring and treatment according to national guidelines.  However there are still 
a minority of adults (14%) and adolescents in paediatric care (10%) who were not 
treated according to national guidelines.  Furthermore it is of some concern that 
adult specialist diabetes services were managing DKA in a small number of 
children down to 10 years of age, using adult guidelines.  In addition, a significant 
proportion of each group developed hypoglycaemia and /or hypokalaemia during 
treatment.  
 
 
The identified precipitating causes were different between the groups, with non-
adherence identified in around half of the paediatric patients, but only a quarter of 
the adult patients.  The fact that 37% of the paediatric group and 42% of the adult 
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patients had had at least 1 episode of DKA in the previous 12 months (up to 7 
admissions in one patient) suggest that many of the admissions are a result of non-
adherence, even though adult patients are more likely to be recorded with 
‘gastroenteritis’.  Investigation routinely includes a chest X-ray in the adult patients, 
although none were reported to have pneumonia or any other condition which 
would be identified on a chest X ray.  In young adults under the age of 22 years, 
this could be removed from the guidelines as a routine investigation, but left to 
clinical discretion, as in children.    
 
In the National Paediatric Diabetes Audit, around a third of DKA episodes were at 
the diagnosis of diabetes [13].  However in our survey, only 4 patients (3.0%) were 
newly diagnosed.  This is a very low number but may be because young people 
aged 14 and above are less likely to present in DKA at diagnosis than younger 
children (4-11% compared with 23-15% in children under the age of 4 years [13]).   
Seven patients (1 paediatric and 6 adult) developed DKA as an existing in-patient.  
This is clearly a major safety concern.  This has been identified as a particular 
problem in the National Diabetes Inpatient Audit in adults [1] and is currently a 
focus of improved training of ward nurses and junior doctors in the importance of 
monitoring of diabetes, and adequate insulin replacement [14].  
 
Fluid and Insulin management  
Although a large paediatric randomised study of various fluid regimes is currently 
underway in the US [15], in the UK the use of 0.9% sodium chloride solution 
(‘normal saline’) is now almost universal in both adult and paediatric services.  In 
the paediatric patients, those receiving a sodium chloride bolus had a lower pH.   
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A small number of adult patients (17%) received an insulin bolus, despite 
guidelines which do not recommend it, and two of these patients were under the 
age of 18 years.  This is not appropriate treatment because in children under 18, 
the JBDS guideline recommends that the paediatric BSPED guideline is followed, 
which advises against a bolus dose of insulin because it is unnecessary and in this 
age-group it can increase the risk of cerebral oedema [7].    Furthermore paediatric 
guidelines recommend a delay in starting insulin for at least an hour after starting 
intravenous fluids, because early insulin has been shown to increase the risk of 
cerebral oedema [7].  This recommendation is being followed in the paediatric 
patients who started insulin 100 minutes after admission, compared to 39 minutes 
in the adult patients, but this is another concern for children who are being treated 
with adult guidelines.  
 
Monitoring during management 
Not all patients, either adult or paediatric, appear to have been seen by senior 
doctors during the early management.  Only 69% responders felt that an 
appropriate monitoring strategy had been established in the adult patients 
(compared to 85% in the paediatric patients); lower rates of regular monitoring of 
capillary glucose, vital signs etc were recorded in adults.  90% of all patients had 
their blood ketone levels measured initially, but only 60% repeatedly through the 
episode.  
 
One third of all patients, both adult and paediatric, developed hypoglycaemia.  In 
adult patients hypoglycaemia has been shown to be a strong predictor for 
 14 
increased length of hospital stay and mortality [16].   This suggests that either the 
insulin dose (fixed rate or bolus) was excessive.  None of the paediatric patients 
started on the 0.05 Units/kg/hour insulin infusion developed hypoglycaemia, but in 
order to convincingly answer the question of which dose is safer, a randomised 
controlled trial of 0.1 Units/kg/hour compared with 0.05 Units/kg/hour needs to be 
carried out in both children and young adults [17,18].  Also a much smaller number 
of paediatric patients were changed to 10% glucose (52% compared with 80% 
adults) when their blood glucose level fell.   
 
Hypokalaemia also occurred in large numbers of patients, but there was more than 
twice the incidence of hypokalaemia in the adult compared with the paediatric 
patients, although no[KD6] evidence of harm.  Both JBDS and BSPED guidelines 
suggest adding 40 mmol potassium per litre of intravenous fluid, but the JBDS 
guidelines recommend that no potassium be prescribed if the serum potassium 
level remains above 5.5 mmol/l and it should only be added if the patient is passing 
urine [9].  Since most of the difference of the fall of blood potassium levels which 
we observed, occurred during the first 2 hours of treatment (figure 2), it is possible 
that the delay while waiting for urine to be produced may be important.   The delay 
in starting the insulin infusion for at least an hour after the start of intravenous fluids 
may also help to prevent an early fall in potassium levels in the paediatric[KD7] 
patients.  
 
Resolution of DKA and discharge 
The majority of adult and paediatric patients (over 90%) were referred to and seen 
by the diabetes team before discharge. However, the vast majority of all children 
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and young people did not receive psychological support prior to discharge.  The 
provision of this service is known to be lacking in many teams although generally 
advocated as an important part of a diabetes team.  The higher rate of paediatric 
psychology input compared to the adult services (11.4% vs 5.6%) may be a 
reflection of the increased psychology provision through the Best Practice Tariff in 
England [19].  It would be very beneficial if this tariff could also be extended to 
adult services for young people up to the age of 25 years, especially as a high 
proportion of the episodes of DKA are related to adherence difficulties.   
 
Limitations of the Study 
We asked for voluntary contributions from teams across the UK, and for unselected 
sequential cases, but come case selection may have occurred. Despite this, we 
feel that the forms returned are likely to be a good representation of patients 
presenting daily to emergency adult teams and paediatric services across the UK 
and elsewhere, and this is the largest study of its kind reported.  This survey was 
not designed to look at prevalence or risk factors of DKA, but rather at quality of 
management.    
 
Summary 
These data represent the largest ever nationwide survey on the management of 
DKA.  For the first time this has allowed a comparison of the management and 
outcomes in adolescents and young people from the age of 14 to 22, managed in 
paediatric and adult services.   Although guidelines are largely followed in both 
groups, we have highlighted a small group of children being treated with adult 
guidelines, which is a concern.  There is a significant risk of hypokalaemia in the 
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adult patients and of hypoglycaemia in both groups.  This suggests that the 
potassium and glucose replacement regimens, and insulin replacement, need to be 
studied further in randomised trials in both paediatric and adult services.  We feel 
that adult and paediatric teams need to work together to produce the safest 
guidelines for adolescents and young adults, who may have different requirements 
from older adults.   
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Legends  
Table 1 
Care setting in Paediatric patients compared with Adult patients. Shaded boxes 
show major differences. 
 
Table 2 
Precipitating cause for the episode of DKA in Paediatric patients compared with 
Adult patients (more than one cause in some patients).  Shaded boxes show major 
differences. 
 
Table 3 
Management of the Paediatric and Adult patients in the first hour after diagnosis of 
DKA was made. The number and percentage of missing data for each variable is 
shown.  Shaded boxes show major differences. 
NA = not applicable 
JBDS – Joint British Diabetes Societies for Inpatient Care Group 
BSPED – British Society of Paediatric Endocrinology and Diabetes  
ICU – Intensive Care Unit 
ECG – Electrocardiogram 
CXR – Chest X-Ray 
 
Table 4 
Ongoing DKA management, outcome and discharge.  The number and percentage 
of missing data for each variable is shown.  Shaded boxes show major differences.  
NA = not applicable 
 
Figure 1  
Changes in plasma pH over time.  Paediatric values in the dashed line and adult 
values in the solid line.  Results are shown as mean of all values at each hour. 
 
Figure 2 
Changes in plasma potassium levels over time.  Paediatric values in the dashed 
line and adult values in the solid line. Results are shown as mean and standard 
deviations of all values at each hour. 
 
Online Appendices 1 and 2 
Questionnaires sent to all adult and paediatric diabetes teams in all UK hospitals  
 
Online Appendix 3 
List of all contributing hospitals   
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Table 1  
  Paediatric (n=71) Adult (n=64) 
Gender Male 53.5% 50% 
 Female 46.5% 50% 
Treatment 
Area 
Level 1 (General ward) 21.4% 10.9% 
 Level 2 (High 
dependency) 
41.4% 12.5% 
 Level 3 (Intensive care) 2.9% 12.5% 
 Acute Medical Unit 5.7% 43.8% 
 Accident and Emergency 18.6% 10.9% 
 Combination 8.6% 9.4% 
 Missing data 1.4% 0 
 
Table 2 
Precipitating cause of DKA identified  
 
Paediatric (n=62) Adult (n=50) 
   
New diabetes diagnosis 1 (1.4%) 3 (4.5%) 
Infection 9 (12.7%) 14 (21.9%) 
Alcohol 2 (2.8%) 4 (6.3%) 
Gastroenteritis 7 (9.9%) 9 (14.1%) 
Non-adherence 37 (52.1%) 16 (25%) 
Appendicitis/pancreatitis 0 2 (3.1%) 
Insulin pump problems 5 (7.0%) 0  
Psychological including anorexia 2 (2.8%) 3 (4.5%) 
No precipitating cause identified  8 (11.3%) 13 (20.3%) 
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Table 3 
 Paediatric Reports (n=71) Adult Reports (n=64) 
Variable Yes (%) No (%) 
Missing / N/A 
 (n (%)) 
Yes (%) No (%) 
Missing / N/A 
 (n (%)) 
Was the diagnosis made using JBDS 
criteria? 
77.5 1.4 15 (21.1) 59.4 1.6 25 (39.0) 
Seen by ICU or a senior within 12 hours of 
admission? 
76.1 18.3 4 (5.6) 84.4 6.2 6 (9.3) 
Was care given according to BSPED/JBDS 
guidelines? 
84.5 9.6 4 (5.6) 76.6 14.1 6 (9.3) 
Was the care given in an appropriate area? 100 0 0 93.4 3.1 2 (3.1) 
Was a bolus insulin dose given? n/a n/a n/a 17.2 78.1 3 (4.7) 
Was a fixed rate insulin infusion used? 98.6 1.4 0 95.3 4.7 0 
Was the insulin infusion started at 0.05 
units/kg/hour? 
12.9 87.1 0 n/a n/a n/a 
Was the insulin infusion started at 0.1 
units/kg/hour? 
87.1 12.9 0 100 0 0 
Was a bolus of 0.9% sodium chloride 
solution given? 
63.4 32.4 3 (4.3) n/a n/a n/a 
Was intravenous 0.9% sodium chloride 
solution used? 
98.6 1.4 0 98.4 1.6 0 
Potassium replacement in accordance with 
local protocol? 
93.0 4.2 2 (2.8) 82.8 9.4 5 (7.8) 
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Early warning score recorded? 74.7 14.1 8 (11.3) 90.6 6.3 2 (3.1) 
Respiratory rate recorded? 91.6 0 6 (8.4) 98.4 0 1 (1.6) 
Temperature recorded? 91.6 0 6 (8.4) 98.4 0 1 (1.6) 
Pulse rate recorded? 91.6 0 6 (8.4) 100 0 0 
Oxygen saturations recorded? 91.6 0 6 (8.4) 100 0 0 
Glasgow come scale recorded? 98.6 1.4 0 90.6 6.3 2 (3.1) 
Full history recorded? 100 0 0 96.9 3.1 0 
Full examination recorded? 100 0 0 89.1 4.7 4 (6.2) 
Blood ketones recorded? 91.6 8.4 0 89.1 10.9 0 
Capillary blood glucose recorded? 97.2 2.8 0 98.4 1.6 0 
Venous plasma glucose recorded? 88.7 7.0 3 (4.2) 96.9 1.6 1 (1.6) 
Urea and electrolytes recorded? 98.6 1.4 0 100 0 0 
Venous blood gases recorded? 93.0 7.0 0 90.6 7.8 1 (1.6) 
Full blood count performed? 97.2 1.4 1 (1.4) 90.6 3.1 4 (6.3) 
ECG performed? 23.9 63.4 9 (12.7) 73.4  20.3 4 (6.3) 
CXR performed? 12.7 77.5 7 (9.9) 64.1 28.1 5 (7.8) 
Urinalysis performed? 78.9 18.3 2 (2.8) 67.2 20.3 8 (12.5) 
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Table 4  
 Paediatric Reports (n=71) Adult Reports (n=64) 
Variable Yes (%) No (%) 
Missing data 
/ NA  (n (%)) 
Yes (%) No (%) 
Missing data 
/ NA (n (%)) 
Was an appropriate monitoring regimen 
established? 
84.5 11.3 3 (4.2) 68.8 28.1 2 (3.1) 
Capillary glucose levels measured hourly? 95.8 4.2 0 84.4 14.1 1 (1.6) 
Ketone levels measured hourly? 69.0 31.0 0 67.2 28.1 3 (4.7) 
Observations of vital signs taken hourly? 97.2 2.8 0 68.8 26.6 3 (4.7) 
Early warning score measured hourly? 77.5 19.7 2 (2.8) 62.5 32.8 3 (4.7) 
Urine output documented? 71.8 25.4 2 (2.8) 68.8 26.6 3 (4.7) 
If patient was already on long-acting insulin, 
was this continued? 
45.1 
(n=53) 
29.6 0 
88.4  
(n=43) 
11.6 0 
Was 10% glucose started when the glucose 
dropped to <14mmol/l? 
52.1 38.0 7 (9.9) 82.8 10.9 4 (6.3) 
Review of fluid balance with the rate of 
normal saline amended if appropriate? 
67.6 14.1 13 (18.3) 65.6 7.8 17 (26.6) 
Did the patient ever develop 
hypoglycaemia? 
43.7 56.3 0 35.9 62.5 1 (1.6) 
If progress was not satisfactory, did a senior 
review occur? 
100  
(n=24) 
0 0 
100 
(n=19) 
0 0 
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Was the transition to subcutaneous insulin 
managed appropriately? 
93.0 4.2 2 (2.8) 84.4 10.9 3 (4.7) 
Was a referral to diabetes team made 
during admission? 
85.9 5.6 6 (8.5) 90.6 3.1 4 (6.3) 
After DKA resolution, were they reviewed by 
the diabetes team? 
93.0 7.0 0 96.9 1.6 1 (1.6) 
Did the patient receive education support 
before discharge? 
84.5 12.7 2 (2.8) 89.1 1.6 6 (9.4) 
Did the patient receive psychological 
support before discharge? 
11.3 80.3 6 (8.5) 6.3 84.4 6 (9.4) 
 
 
